# A Bayesian phase I/II biomarker-based design for identifying subgroup-specific optimal dose for immunotherapy

> Research article (Statistical Methods in Medical Research, 2022) · cited 12× · AI/ML

**Wikidata**: [openalex:W4212795289](https://www.wikidata.org/wiki/openalex:W4212795289)  
**Source**: https://4ort.xyz/entity/a-bayesian-phase-i-ii-biomarker-based-design-for-identifying-subgroup-specific-optimal-dose-for-immunotherapy